Pharmacoeconomic comparison of Helicobacter pylori eradication regimens

被引：0
作者：
Mesut Sancar
Fikret Vehbi Izzettin
Sule Apikoglu-Rabus
Fatih Besisik
Nurdan Tozun
Gul Dulger
机构：
[1] Marmara University,Clinical Pharmacy Department, Faculty of Pharmacy
[2] Istanbul University,Gastroenterology Department, Faculty of Medicine
[3] Marmara University,Gastroenterology Department, Faculty of Medicine
[4] Marmara University,Pharmacology Department, Faculty of Pharmacy
来源：
Pharmacy World and Science | 2006年 / 28卷
关键词：
Cost-effectiveness; Eradication regimens; Gastritis; Helicobacter pylori; Peptic ulcer; Pharmacoeconomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 214
页数：7
相关论文
共 109 条
  • [1] Marshall BJ(1984)Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1311-1315
  • [2] Warren JR(1997): new developments and treatments Can Med Assoc J 156 1565-1572
  • [3] Veldhuyzen SO(1996)The influence of drug dosage on Am J Gastroenterol 91 246-257
  • [4] Sherman PM(2005) eradication: a cost-effectiveness analysis Med J Aust 183 612-614
  • [5] Hunt RH(1996)The 2005 Nobel Prize in physiology or medicine. The Gastroenterology 110 926-938
  • [6] Treiber G(1997) story illustrates some of the human hallmarks of revolutionary research Gastroenterology 113 S15-S20
  • [7] Van Der Weyden MB(1995) and gastric acid: biological and therapeutic implications Lancet 345 1591-1594
  • [8] Armstrong RM(1997)What are the host factors that place an individual at risk for Aliment Pharmacol Ther 11 95-101
  • [9] Gregory AT(2000)-associated disease? Gastroenterol Clin N Am 29 837-851
  • [10] McGowan CC(1995)Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of JAMA 274 1064-1066
12345678910